fbpx
April 27, 2023

Intraoperative Pathology Spurs Overtreatment in Mastectomy Intraoperative Pathology Spurs Overtreatment in Mastectomy

Early stage breast cancer patients who undergo a mastectomy and have a pathological analysis of their sentinel lymph nodes (SLN) performed during surgery are more likely […]
April 27, 2023

Preop MRI Does Not Reduce Positive Margins in Breast Surgery Preop MRI Does Not Reduce Positive Margins in Breast Surgery

BOSTON — Having a preoperative MRI scan does not help surgeons to reduce the likelihood of positive surgical margins when they are performing lumpectomy for early-stage […]
April 27, 2023

Mammography After Breast Cancer for Older Patients Mammography After Breast Cancer for Older Patients

BOSTON — Older women who have had breast cancer frequently undergo annual surveillance mammography, even if there is only a small risk of their developing a second […]
April 27, 2023

Tirzepatide Scores Win in Second Obesity Trial, SURMOUNT-2 Tirzepatide Scores Win in Second Obesity Trial, SURMOUNT-2

The “twincretin” tirzepatide (Mounjaro) has proven successful in SURMOUNT-2, the second pivotal trial for the drug as an antiobesity agent, according to top-line results reported today […]
April 26, 2023

Does Young-Onset Adenoma Require More Intense Surveillance? Does Young-Onset Adenoma Require More Intense Surveillance?

For adults who develop adenomas before age 50, the risk of developing colorectal cancer (CRC) and dying from it is low, especially for nonadvanced adenomas, but […]
April 26, 2023

IPL-RF Combination Effective for Dry Eyes in Small Study IPL-RF Combination Effective for Dry Eyes in Small Study

PHOENIX – Combining intense pulsed light (IPL) with topical radiofrequency (RF) for dry eye disease related to meibomian gland dysfunction resulted in about a doubling of meibomian gland […]
April 26, 2023

Study Focuses on Adolescent Data in Upadacitinib AD Trials Study Focuses on Adolescent Data in Upadacitinib AD Trials

The Janus kinase (JAK) inhibitor upadacitinib is an effective and well-tolerated treatment option for adolescents with moderate to severe atopic dermatitis (AD), an analysis of three clinical trials […]
April 26, 2023

Lose Weight, Gain Huge Debt Lose Weight, Gain Huge Debt

Seven months after Lahavah Wallace’s weight loss operation, a New York bariatric surgery practice sued her, accusing her of “intentionally” failing to pay nearly $18,000 of […]
April 26, 2023

Why Is Buprenorphine Use Flatlining? Why Is Buprenorphine Use Flatlining?

Initiation of buprenorphine in hospitals in the United States has plateaued since 2018, with low retention rates of less than 25%, based on data from more […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630631632633634635636637638639640641642643644645646647648649650651652653654655656657658659660661662663664665666667668669670671672673674675676677678679680681682683684685686687688689690691692693694695696697698699700701702703704705706707708709710711712713714715716717718719720721722723724725726727728729730731732733734735736737738739740741742743744745746747748749750751752753754755756757758759760761762763764765766767768769770771772773774775776777778779780781782783784785786787788789790791792793794795796797798799800801802803804
Next page
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0